DREW SODA: Open Payments
NPI 1679233142 · NEW HOPE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$124,225 in 513 payments from 23 companies in 2025. Trend: 2023 $21,004 · 2024 $61,375 · 2025 $124,225
Speaker / faculty: $90,101Honoraria: $12,375Consulting: $7,959Food & beverage: $7,407Travel & lodging: $6,099Education: $285
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 85 | $33,036 |
| Botanix SB Inc | 44 | $21,482 |
| ABBVIE INC. | 87 | $15,288 |
| Galderma Laboratories, L.P. | 41 | $15,033 |
| Organon LLC | 39 | $14,091 |
| LEO Pharma Inc. | 41 | $13,879 |
| Incyte Corporation | 29 | $5,898 |
| Janssen Biotech, Inc. | 33 | $3,150 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 20 | $491 |
| UCB, Inc. | 29 | $459 |
Products named: EBGLYSS, SOFDRA, NEMLUVIO, RINVOQ, VTAMA, ANZUPGO, OPZELURA, TREMFYA.
Industry payments across PA — which companies pay providers there.
